Search results
Face filler expected to soar with cases of gaunt ‘Ozempic face’ — and one company is cashing in
New York Post· 1 hour agoA saggy, sunken face is a hallmark of Ozempic use, but one pharmaceutical company wants to fix that....
Analyst Report: Evotec SE
Morningstar Research via Yahoo Finance· 2 hours agoEvotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit ...
Hemogenyx Pharmaceuticals outlines significant progress with HEMO-CAR-T in 2023
Proactive Investors· 1 hour agoHemogenyx Pharmaceuticals PLC (LSE:HEMO, OTC:HOPHF) CEO ...Proactive's Stephen Gunnion that 2023 was...
Biodexa secures rights to eRapa for FAP treatment By Investing.com
Investing.com· 3 hours agoBiodexa Pharmaceuticals PLC (NASDAQ:BDRX), a clinical-stage biopharmaceutical company, announced...
4 Large Drug Stocks to Hold on to Amid Industry Challenges
Zacks via Yahoo Finance· 2 days agoDrug and biotech companies are likely to see significant innovation. In the Large-Cap ...
Oncologists' meetings with drug reps don't help cancer patients live longer
WUSF 89.7· 4 days agoPharmaceutical company reps have been visiting doctors for decades to tell them about the latest...
...Establish Joint Venture Company for Incubation of Early Drug Discovery Programs...OTC:ALPMY),...
Benzinga· 4 days agoTakeda Pharmaceutical Company Limited TAK President and CEO, Christophe Weber, ", Takeda", ))), Astellas...signed a master agreement on April 22, 2024, ...
Needham & Company LLC Reaffirms Hold Rating for Lexicon Pharmaceuticals (NASDAQ:LXRX)
ETF DAILY NEWS· 9 hours agoNeedham & Company LLC reaffirmed their hold rating on shares of Lexicon Pharmaceuticals (NASDAQ:LXRX – Free Report) in a research report released on Tuesday ...
Recce Pharmaceuticals R327 approved for increase to 4,000mg IV over a fast infusion of 30 minutes
Proactive Investors· 5 hours agoThe Independent Safety Committee has approved an increase of Recce Pharmaceuticals Ltd (ASX:RCE,...
Top 20 biopharma kick off 9.6% market cap surge in Q1 2024 amid Medicare price talks
Pharmaceutical Technology via Yahoo Finance· 59 minutes agoWith ongoing Medicare negotiations, the industry is adjusting by raising drug prices in anticipation...